Lupus News

The EULAR/American College of Rheumatology 2019 classification criteria for systemic lupus erythematosus did not perform significantly better than the ACR 1997 and SLICC 2012 criteria, according to findings published in Arthritis Care & Research.

Patients with psoriatic arthritis demonstrate a 2.3-fold increased prevalence for systemic lupus erythematosus, compared with the general population, according to data published in The Journal of Rheumatology.

Women aged 18 to 45 years with rheumatic diseases want rheumatologists to play an active role in their sexual and reproductive health, according to findings from a series of interviews published in Arthritis Care & Research.

Patients with rheumatic diseases plus COVID-19 are more likely to require mechanical ventilation, but demonstrated similar clinical features and hospitalization rates as those with COVID-19 only, according to data published in the Annals of the Rheumatic Diseases.

The FDA has issued a warning letter to MediNatura Inc., ordering the company to cease illegal marketing of unapproved injectable homeopathic products that claim to treat “inflammatory and degenerative conditions of the musculoskeletal system” and relieve pain, swelling and joint stiffness.

The FDA has rescinded the emergency use authorization, or EUA, for hydroxychloroquine for the treatment of COVID-19, according to a letter from RADM Denise Hinton, the FDA’s Chief Scientist.

Patients with systemic lupus erythematosus who received hydroxychloroquine were just as likely to develop severe COVID-19 as those who were not treated with antimalarials, according to data from the COVID-19 Global Rheumatology Alliance registry.

Thrombosis rates among patients with systemic lupus erythematosus decrease 13% for every increase of 200 ng/mL in mean hydroxychloroquine in the blood, according to data presented at the EULAR 2020 virtual congress.

Patients with systemic lupus erythematosus had a significantly increased risk for antimalarial-induced retinopathy, possibly due to prolonged exposure to those drugs, according to a data presented at the EULAR 2020 E-Congress.

Lifestyle approaches, including physical activity and smoking cessation, should complement medical therapy in patients with rheumatic and musculoskeletal diseases, according to data presented at the EULAR 2020 E-Congress.